Navigation Links
Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions
Date:3/2/2015

San Diego, CA (PRWEB) March 02, 2015

In light of the FDA's approved revisions to the safety label of anticoagulant Xarelto (rivaroxaban) tablets, Ford & Associates Nationwide Legal Services notes that these cautionary revisions may be helpful for future users, but may come too late for individuals who have already allegedly suffered injuries from taking the drug. The FDA has now included the term “thrombocytopenia,” a low blood platelet disorder, under Adverse Reactions on Xarelto's label. The term “cytolytic hepatitis” has also been replaced with “hepatitis (including hepatocellular injury).” *

Lawsuits against Xarelto allege that Janssen Pharmaceuticals, Inc., the manufacturer of Xarelto, knew of the possibility of internal bleeding and other Xarelto side effects, but didn't adequately warn of such events. According to case documents, individuals who took Xarelto have allegedly experienced severe bleeding, strokes, and fatal injuries leading to death.

“We acknowledge the FDA's Adverse Reactions revisions to Xarelto's labeling, and are interested in talking with people who took Xarelto prior to these revisions, and may have suffered injuries as a result. We are committed to helping people find the best legal representation possible, and encourage them to contact us.” – Mateo Martinez, Ford & Associates Case Manager

Xarelto (rivaroxaban) was on FDA’s 2011 Innovative Drug Approval List as a new anticoagulant used to prevent the formation of blood clots in patients who suffer from deep vein thrombosis (DVT), atrial fibrillation (irregular heart rhythms), pulmonary embolism (PE), and are at high risk of stroke. Xarelto is marketed as superior and easier to use than other anticoagulants, as the drug doesn't require dietary restriction, or tests to monitor the patients’ blood plasma levels.**

Although the FDA notes that Xarelto doesn't at present have an antidote to stop severe bleeding if it should occur, Ford & Associates has learned of studies, as reported by Reuters, that an intravenous antidote, andexanet alfa, has been developed, and is being tested for accuracy to reverse the anticoagulation activity associated with Xarelto use. Current trial data indicates that the Portola Pharmaceuticals anti-clotting drug has already experienced a high success rate of reversing internal bleeding associated with Xarelto in healthy patients aged 50-75. More testing details are suspected to be released within the coming year.***

Ford & Associates also comments that there are currently 21 Xarelto lawsuits filed and pending against the manufacturers of Xarelto (Case MDL No. 2592). In December of 2014, the U.S. Judicial Panel on Multidistrict Litigation centralized all federally-filed Xarelto lawsuits to the U.S. District Court, Eastern District of Louisiana. The U.S. Judicial Panel stated there were common issues in all Xarelto cases that allowed for centralization, such as “the adequacy of Xarelto’s warning label with respect to the risk of severe bleeding and other injuries, the results of certain clinical studies, and the alleged need for blood monitoring.” (Case MDL No. 2592).

*fda.gov/Safety/MedWatch/SafetyInformation/ucm367392.htm, FDA, December 2014
** fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/UCM278358.pdf, FDA, February 2011
*** reuters.com/article/2015/01/09/us-portola-pharma-study-idUSKBN0KI1DR20150109, Reuters, January 2015

About Ford & Associates Nationwide Legal Services, A.P.C.
Ford & Associates Nationwide Legal Services, A.P.C., is a San Diego based law firm that fights aggressively for the rights of those who cannot fight for themselves. Each case is treated with unparalleled dedication, compassion, and skill, and pursued to the fullest extent as allowed by law until a favorable outcome has been reached.

If you or a loved one believe that you have suffered adverse health conditions from using Xarelto, and are seeking answers to Xarelto lawsuit and/or rivaroxaban lawsuit questions, contact Ford & Associates today at 1-866-242-0905 for a free, no-obligation case review.

Ford & Associates Nationwide Legal Services, A.P.C.
3555 4th Ave
San Diego, CA 92103
866-242-0905

ATTORNEY ADVERTISING. Ford & Associates Nationwide Legal Services, APC. This is an attorney advertisement. The information in this article is only provided for general information purposes. The information presented in this article and your viewing of the information in this article does not establish an attorney-client relationship. If you need legal assistance, we encourage you to call, write or email us. By contacting us, an attorney-client relationship has not been created. A formal attorney client-client relationship is not established until you have signed a retainer agreement and your case has been accepted. Please do not send any documents, evidence or any other information relating to your case until an attorney-client relationship has been established. Prior results do not guarantee a similar outcome with respect to any future matter. Please call or email our firm for a free, no obligation case evaluation.

Contact Information:
Mateo Martinez, Case Manager
Ford & Associates Nationwide Legal Services, A.P.C.
3555 4th Ave
San Diego, CA 92103
866-242-0905
drug-lawsuits.com

Read the full story at http://www.prweb.com/releases/2015/02/prweb12485242.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo.
2. Benedict Advertising & Marketing Signs Sedation Systems
3. J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale
4. Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale
5. New Sparrow Charmer & Sparrow Sky Trap Combo Delivers One-Two Punch to Sparrow Problem
6. PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award
7. Bnatrl Launches Prenatal Multivitamin & Mineral Supplement Made from Raw Whole Foods
8. Second Annual Ko Olina Children’s Film & Music Festival Features Frozen At Sunset And Young Local Music Line-Up
9. Edvance360 LMS-SN Partners with MegaMeeting.com, a 100% Browser-Based Web & Video Conferencing System
10. Dimethyl sulfoxide (DMSO) Industry 2015-2020 Global Trends & Forecasts Report Now Available at DeepResearchReports.com
11. Parker & Sons Announces Record Demand For Residential Plumbing Services In The Greater Phoenix Metropolitan Area
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2019)... ... September 18, 2019 , ... A new study by BestPlaces looks at ten indicators to produce ... only Federally-mandated right, so other related rights vary widely across the 50 states. ... an individual's sexual orientation) , Employment , Education , ...
(Date:9/17/2019)... ... September 17, 2019 , ... Encouraging ... has earned Michael Cole, Vice President of Insurance Plan Management for Dental Care ... of Dental Plans (NADP) at their annual conference, CONVERGE 2019, in Orlando. This ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... and Dental Implants welcome patients with missing teeth in Chattanooga, TN for customized ... by a periodontist in as little as one day, providing a permanent tooth ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... CA, recently announced that he has been certified by the American Academy of ... is used to correct a wide range of orofacial conditions such as tooth ...
(Date:9/17/2019)... ... September 17, 2019 , ... CORE Medical & Wellness, a ... Gartshteyn to their team of expert physicians. Dr. Gartshteyn completed her Rheumatology Clinical ... of Assistant Professor in Medicine for the Division of Hospitalist Medicine. , Dr. ...
Breaking Medicine News(10 mins):
(Date:9/12/2019)... , ... September 12, 2019 , ... ... to help make the services of CPESN’s clinically integrated network of more than ... CPESN USA’s participating pharmacies provide high quality clinical service programs that will ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) today announced it ... Pharmaceutical Technology Ltd (SNPT), an API manufacturing facility in Changshu Economic Technology ...
(Date:9/11/2019)... PITTSBURGH (PRWEB) , ... September 11, 2019 , ... Pressley ... for Autism and School for the Deaf on September 20 at 1 p.m. on ... have been in operation for many years, this is the first time they have ...
Breaking Medicine Technology: